Lab21 Limited - Product Pipeline Analysis

1
Lab21 Limited - Product Pipeline AnalysisMarket
Research Reports Distributor - Aarkstore.com have
vast database on market research reports, company
financials, company profiles, SWOT analysis,
company report, company statistics, strategy
review, industry report, industry research to
provide excellent and innovative service to our
report buyers.Aarkstore.com have very
interactive search feature to browse across more
than 2,50,000 business industry reports. We are
built on the premise that reading is valuable,
capable of stirring emotions and firing the
imagination. Whether you're looking for new
market research report product trends or
competitive industry analysis of a new or
existing market, Aarkstore.com has the best
resource offerings and the expertise to make sure
you get the right product every time.
2
Lab21 Limited - Product Pipeline Analysis

• SummaryLab21 Limited (Lab21) is a personalized
  healthcare company. The company offers diagnostic
  products and services and supports medical
  diagnostics, blood bank screening and drug
  discovery. Lab21serves pharmaceutical and
  diagnostic firms and international healthcare
  providers. Lab21s diagnostic product division
  manufactures immuno-diagnostic kits and reagents
  which is focused on infectious diseases for the
  blood banking and clinical markets. Its clinical
  services operations provides high technology
  molecular assays and companion diagnostics. Lab21
  has office in South Carolina, the US and
  Cambridge, the UK with a GMP manufacturing
  facility in Cambridge and other manufacturing
  sites in Camberley, Bridport and Newmarket. The
  company is headquartered in Cambridge, the
  UK.The company plans to develop fully automated
  polymerase chain reaction based assays on the BD
  MAX platform as recently it entered into a
  collaboration with Becton, Dickinson and
  Company.This report is a source for data,
  analysis and actionable intelligence on the Lab21
  Limited portfolio of pipeline products. The
  report provides detailed analysis on each
  pipeline product with information on the
  indication, the development stage, trial phase,
  product milestones, pipeline territory, estimated
  approval date, and estimated launch dateEach
  pipeline product is profiled to cover information
  on product description, function, technology,
  indication, and application. The report is also
  supplemented with a detailed company profile and
  information on clinical trials, wherever
  applicable.This report is built using data and
  information sourced from proprietary databases,
  primary and secondary research and in-house
  analysis by GlobalDatas team of industry
  experts.

3

• Scope- Detailed company profile with
  information on business description, key company
  facts, major products and services, key
  competitors, key employees, locations and
  subsidiaries and recent developments.- Detailed
  coverage on all the pipeline products, by
  equipment type, by therapy area, by development
  stage, and by trial phase.- Information on
  product milestones and pipeline territory for
  each product, the estimated approval date, and
  estimated launch date.- Profile of each pipeline
  product with additional information on product
  description, function, technology, indication(s),
  and application.- Data on relevant clinical
  trials and product patent details, wherever
  applicable.- Information on clinical trial,
  wherever applicable, is supplemented with
  information on trial phase, trial status, trial
  objective, trial design, target patients, unique
  physician identifier, primary point, secondary
  point, acronym, participants inclusion,
  participants exclusion, interventions, trial
  results, trial start date, trial end date, study
  type, trial site, trial funding, age eligibility,
  and gender eligibility.
• Reasons to Buy- Develop business strategies by
  understanding the trends and developments driving
  the medical devices pipeline and technology
  landscape globally.- Design and develop your
  product development, marketing and sales
  strategies.- Exploit MA opportunities by
  identifying market players with the most
  innovative pipeline.- Develop market-entry and
  market expansion strategies.- Exploit
  in-licensing and out-licensing opportunities by
  identifying products, most likely to ensure a
  robust return.- Identify emerging players with
  potentially strong product portfolio and create
  effective counter-strategies to gain competitive
  advantage.- Develop competition strategies by
  identifying the status and likely launch of your
  competitors pipeline products through review of
  the clinical trials, stage and phase of
  development, etc.- Which are the next high-value
  products that your competitor would add in its
  portfolio? identify, understand and capitalize.

4

• List of Tables 3List of Figures 3Key Facts
  4Lab21 Limited - Major Products and Services
  5Lab21 Limited Pipeline Products by Equipment
  Type 6Lab21 Limited Pipeline Products by
  Development Stage 8Lab21 Limited Pipeline
  Products by Therapy Area 10Lab21 Limited
  Pipeline Products by Milestone Summary
  12Companion Diagnostic Test - Infectious Disease
  14Companion Diagnostic Test - Infectious Disease
  Product Status 14Companion Diagnostic Test -
  Infectious Disease Product Description
  14MycAssay Aspergillus Test 15MycAssay
  Aspergillus Test Product Status 15MycAssay
  Aspergillus Test Product Description 15MycAssay
  Aspergillus Test Product Milestone 15MycAssay
  Pneumocystis Test 17MycAssay Pneumocystis Test
  Product Status 17MycAssay Pneumocystis Test
  Product Description 17MycAssay Pneumocystis Test
  Product Milestone 17Onconostica 19Onconostica
  Product Status 19Onconostica Product Description
  19Lab21 Limited - Key Competitors 20Lab21
  Limited - Key Employees 21Lab21 Limited -
  Locations And Subsidiaries 22Head Office
  22Other Locations Subsidiaries 22Recent
  Developments 23Lab21 Limited, Recent
  Developments 23Jun 26, 2012 Lab21 partners
  pharmaceutical Company To Develop New Companion
  Diagnostic Assay 23May 15, 2012 Lab21 Secures
  European And US Patents For HCV Drug Resistance
  Genotyping 23May 11, 2012 Lab21 Unveils New
  Molecular Analysis Services At Greenville Site
  24Mar 06, 2012 Lab21 And ITOR Launch Clinical
  Genomics Center In US 24Feb 20, 2012 Lab21
  Appoints Fraser Logue As Director Of Quality,
  Regulatory Affairs And Operations Excellence
  24Feb 16, 2012 Lab21 Launches New Lung Cancer
  Companion Diagnostic Service 25Appendix
  26Methodology 26About GlobalData 26Contact Us
  26Disclaimer 26

5

• List of Tables Lab21 Limited, Key Facts 1Lab21
  Limited Key Pipeline Products by Equipment Type
  1Lab21 Limited Key Pipeline Products by Therapy
  Area 1Lab21 Limited Key Pipeline Products by
  Development Stage 1Lab21 Limited, Key Facts
  4Lab21 Limited, Major Products and Services
  5Lab21 Limited Number of Pipeline Products by
  Equipment Type 6Lab21 Limited Pipeline Products
  by Equipment Type 7Lab21 Limited Number of
  Pipeline Products by Development Stage 8Lab21
  Limited Pipeline Products by Development Stage
  9Lab21 Limited Number of Pipeline Products by
  Therapy Area 10Lab21 Limited Pipeline Products
  by Therapy Area 11Lab21 Limited Number of
  Pipeline Products By Milestone Summary 12Lab21
  Limited Pipeline Products by Milestone Summary
  13Companion Diagnostic Test - Infectious Disease
  - Product Status 14Companion Diagnostic Test -
  Infectious Disease - Product Description
  14MycAssay Aspergillus Test - Product Status
  15MycAssay Aspergillus Test - Product
  Description 15MycAssay Aspergillus Test -
  Product Milestone 15MycAssay Pneumocystis Test -
  Product Status 17MycAssay Pneumocystis Test -
  Product Description 17MycAssay Pneumocystis Test
  - Product Milestone 17Onconostica - Product
  Status 19Onconostica - Product Description
  19Lab21 Limited, Key Employees 21Lab21 Limited,
  Subsidiaries 22
• List of Figures Lab21 Limited Key Pipeline
  Products by Equipment Type 1Lab21 Limited
  Pipeline Products by Equipment Type 6Lab21
  Limited Pipeline Products by Development Stage
  8Lab21 Limited Pipeline Products by Therapy Area
  10Lab21 Limited Pipeline Products by Milestone
  Summary 12 

6

• For more information, please visit
• http//www.aarkstore.com/reports/Lab21-Limited-Pro
  duct-Pipeline-Analysis-240115.html
• Or email us at contact_at_aarkstore.com or call
  919272852585
• Related Reports
• 2013 French Hospital Hematology and Flow
  Cytometry Market
• United Arab Emirates In Vitro Diagnostics
  Investment Opportunities, Analysis and Forecasts
  to 2018
• Chile In Vitro Diagnostics Investment
  Opportunities, Analysis and Forecasts to 2018
• Norway In Vitro Diagnostics Investment
  Opportunities, Analysis and Forecasts to 2018
• Aleva Neurotherapeutics SA - Product Pipeline
  Analysis.
• DiaPat GmbH - Product Pipeline Analysis.
• Manhattan Scientifics, Inc. (MHTX) - Product
  Pipeline Analysis.
• MicroTransponder Inc. - Product Pipeline
  Analysis.
• Neurostream Technologies G.P. - Product Pipeline
  Analysis.
• Pop Test LLC - Product Pipeline Analysis.

7

• Contact Us
• Aarkstore Enterprise
• Tel [phone]
• Mobile No08149852585
• Email contact_at_aarkstore.com
• Website http//www.aarkstore.com
• Blog http//www.emarketreports.com
• http//teju-aarkstoreenterprise.blogspot.in
• Follow us on twitter http//twitter.com/aarkstore
  dotcom
• http//in.linkedin.com/in/aarkstore
• http//www.facebook.com/aarkstoreenterprise